BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26700673)

  • 1. miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.
    Wu Z; Li X; Cai X; Huang C; Zheng M
    Tumour Biol; 2016 Jun; 37(6):7939-50. PubMed ID: 26700673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
    Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
    Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
    Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncofetal H19 RNA promotes tumor metastasis.
    Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
    Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer.
    Liu Z; Long J; Du R; Ge C; Guo K; Xu Y
    Tumour Biol; 2016 Jun; 37(6):8327-35. PubMed ID: 26729198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells.
    Lambertini E; Lolli A; Vezzali F; Penolazzi L; Gambari R; Piva R
    BMC Cancer; 2012 Oct; 12():445. PubMed ID: 23031797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
    Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
    Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC
    Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
    Pan Y; Li J; Zhang Y; Wang N; Liang H; Liu Y; Zhang CY; Zen K; Gu H
    Sci Rep; 2016 May; 6():25798. PubMed ID: 27174021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
    Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
    Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
    Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
    J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.